Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders

Valor LM, Viosca J, Lopez-Atalaya JP, Barco A
Magazine Curr Pharm Design
Year 2013
Vol: Pages(start-end) 19(28):5051

Research Groups